Advertisement

Topics

Theravance submits U.S. marketing application for COPD med revefenacin

11:34 EST 13 Nov 2017 | Topix

Theravance Biopharma and development/commercialization partner Mylan N.V. announce the filing of a New Drug Application in the U.S. seeking approval for revefenacin for the once-daily treatment of chronic obstructive pulmonary disease . The companies are collaborating on the development of the long-acting nebulized bronchodilator.

Original Article: Theravance submits U.S. marketing application for COPD med revefenacin

NEXT ARTICLE

More From BioPortfolio on "Theravance submits U.S. marketing application for COPD med revefenacin"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...